HOME >> MEDICINE >> NEWS
Adult socioeconomic position and health of twins

A paper in this month's PLoS Medicine concludes that socioeconomic position in adulthood can significantly affect later health. Nancy Krieger and colleagues from Harvard School of Public Health studied 308 pairs of adult female twins from San Francisco who had been raised together until at least age 14. They found that identical twins who had differing socioeconomic position in adulthood differed in their later health.

In identical twins who differed in social class in adulthood, those who were working class were unhealthier - with significantly higher blood pressure and LDL cholesterol - compared with the professional, non-working-class twin. By contrast, identical twins that differed in their educational attainment only did not have significantly different health status. This study makes it possible to work out the additional impact of adult experiences, including those that occurred after completion of education, on adult health in a population matched on early life experiences.


'"/>

Contact: Paul Ocampo
press@plos.org
415-624-1224
Public Library of Science
25-Jul-2005


Page: 1

Related medicine news :

1. Adult brain cells rediscover their inner child
2. Adult survivors of childhood cancer face long-term health problems, says co-author of national study
3. High BMI Tied to Poor Cognitive Function in Middle-Aged Adults
4. Adults also suffer from cyclical vomiting syndrome
5. Adults with lazy eye can improve
6. Media invitation: 4th International Conference on Teenage and Young Adult Cancer Medicine
7. Adult stem cells aid recovery in animal model of cerebral palsy
8. Adult sickle cell drug proves effective in young children
9. Adult lifestyle biggest risk factor for diabetes, study finds
10. Adults and children use over-the-counter hydrocortisone creams in safe amounts
11. Poor physical fitness associated with lower socioeconomic status and higher rate of death

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Adult socioeconomic position and health twins

(Date:5/4/2015)... Malibu, CA (PRWEB) May 04, 2015 ... of KissSafe™ oral antiseptic breath spray. KissSafe™ is ... making kissing a safer experience while adding fresh ... that safely and effectively kills germs in the ... kissing. It also contains ingredients that possess additional ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Leonardo J. ... and chief physician executive, and William C. Daniel, M.D., ... and accepted personal invitations from the Secretary of the ... Forum (NSF) at the Air War College, Maxwell Air ... expose influential citizens to senior U.S. and international officers ...
(Date:5/4/2015)... 04, 2015 The University of ... launched a new initiative at UC Davis School ... of physicians committed to advancing Latino health. , ... or Preparing Students to Be Physicians, (“Prep Médico” ... provide scholarships, mentorship and internship opportunities, a residential ...
(Date:5/4/2015)... 2015 Takeda Pharmaceuticals Corp. has agreed ... thousands of Actos lawsuits ( http://www.theactoslawsuitcenter.com/ ) that ... that a patient will develop bladder cancer. According ... of those eligible for the Actos settlement accept its ... cases currently pending in courts around the country, including ...
(Date:5/4/2015)... 04, 2015 McNeil & Company ... the expansion of coverage for its Emergency Services ... of industry-tailored insurance and proactive risk management to the ... are dedicated to providing our customers with unparalleled service ... evolving needs. We are excited to launch over 100 ...
Breaking Medicine News(10 mins):Health News:80 Million Germs from Kissing - Introducing KissSafe™ 2Health News:Saint Luke’s Health System Leadership Selected to Attend National Security Forum 2Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 2Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 3Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 4Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 5Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 3Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 3
(Date:5/4/2015)... SAN DIEGO , May 4, 2015 /PRNewswire/ ... an oncology company focused on the clinical development ... pre-clinical data showing mitochondria-specific effects of the Company,s ... significantly enhanced anti-tumor activity when combined with a ... study found ME-344 to be a potent inhibitor ...
(Date:5/4/2015)... , May 4, 2015  FireflySci Inc., the newest member of the cuvette ... launch, they have turned the cuvette industry on its head by offering scientists amazing support for ... Photo - http://photos.prnewswire.com/prnh/20150501/213244 ... ... ...
(Date:5/4/2015)... , May 4, 2015 Dyadic International, ... whose patented and proprietary technologies are used to ... for the bioenergy, bio-based chemical, biopharmaceutical and industrial ... its financial results for quarter ending March 31, ... 2015 and will host a conference call that ...
Breaking Medicine Technology:MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 2MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 3MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 4MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 5New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 2New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 3Dyadic International To Announce First Quarter 2015 Financial Results and Host Conference Call On Thursday, May 14, 2015 2Dyadic International To Announce First Quarter 2015 Financial Results and Host Conference Call On Thursday, May 14, 2015 3
Cached News: